Fig. 3From: Improvement of glycemic control and reduction of major cardiovascular events in 18 cardiovascular outcome trials: an updated meta-regressionMeta-regression analysis between the differences in achieved HbA1c at the end of cardiovascular outcome trials (CVOTs) and the corresponding hazard ratio (HR) for CV death in patients with type 2 diabetes participating in 18 CVOTsBack to article page